Advancement and tribulations in ocular drug delivery

International Journal of Drug Delivery

Volumn 4, Issue 1, 2012, Pages 1-8

  Dave, Vivek ^a   Sharma, Swapnil ^a   Yadav, Sachdev ^a   Paliwal, Sarvesh ^a  

^a BANASTHALI UNIVERSITY   (India)

Author keywords

Gene therapy and ocular inserts; Implant; Lipososme; Microspheres; Niosome

Indexed keywords

ADRENALIN; CARBOMER; CARBOXYMETHYLCELLULOSE; DEXAMETHASONE; DIPIVEFRINE; GANCICLOVIR; GENTAMICIN; HYDROXYPROPYLCELLULOSE; MICRORNA; MICROSPHERE; PILOCARPINE; POLYGLACTIN; POLYLACTIC ACID; PREDNISOLONE ACETATE; PRODRUG; SMALL INTERFERING RNA; AGENTS ACTING ON THE EYE; CHLORAMPHENICOL; ERYTHROMYCIN; IDOXURIDINE; LIPOSOME; NANOPARTICLE; NIOSOME; PENETRATION ENHANCING AGENT; POLYMER; PREDNISOLONE; TETRACYCLINE; TIMOLOL; TOBRAMYCIN; TRIFLURIDINE;

BIODEGRADABILITY; CARDIOVASCULAR DISEASE; CELL ENCAPSULATION; CONTROLLED RELEASE FORMULATION; CYTOMEGALOVIRUS RETINITIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG HYPERSENSITIVITY; DRUG IMPLANT; DRUG RESEARCH; DRUG STABILITY; DRUG TOLERANCE; DRY EYE; EYE BURNING; EYE IRRITATION; EYE PAIN; EYE REDNESS; EYE SWELLING; GENE TARGETING; HUMAN; INTRAOCULAR HYPERTENSION; LIPOSOMAL DELIVERY; MICROENCAPSULATION; NANOPHARMACEUTICS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OCULAR PRURITUS; PATIENT COMPLIANCE; PHOTOSENSITIVITY; RETINA MACULA EDEMA; REVIEW; RISK BENEFIT ANALYSIS; SCLERAL PLUG; VISUAL DISORDER; ARTICLE; BIODEGRADABLE IMPLANT; BLURRED VISION; DRUG DELIVERY DEVICE; DRUG FORMULATION; DRUG POTENCY; DRUG RELEASE; DRUG STORAGE; EMULSION; EYE DISCOMFORT; GENE DELIVERY SYSTEM; OCULAR INSERT; OINTMENT; PARTICLE SIZE; PHASE TRANSITION; SUSPENSION;

EID: 84871271465     PISSN: None     EISSN: 09754415     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Clark AF, Yorio T. Nat Rev Drug Discov. by Macmillan Publishers; 2003; 2, 448-592.
2. Macha S, Mitra AK. Ophthalmic drug delivery systems; second edition revised and expanded. Chapter 1 Overview of Ocular Drug Delivery. 1998; 1-3.
3. Mundada AS, Avari JG, Mehta SP, Pandit SS, Patil AT. Recent advances in ophthalmic drug delivery system. Pharm Rev; 2008; 6(1), 24-26.
4. Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev; 2006; 58:1131-1135.
5. Jtirvinena K, Tomi J, Urttia SA. Ocular absorption following topical delivery. Adv Drug Deliv Rev, 1995; 16:3-19.
6. Patton TF, Robinson JR. Ocular evaluation of PVA vehicle in rabbits. J. Pharm. Sci. 1975, 64, 1312-1315.
7. Calvo D, Vila-Jato JL, Alonso MJ, Evaluation of cationic polymer coated nanocapsules as ocular drug carriers, Int J Pharm, 1997; 153, 41-50.
8. Jacob L, Baure JT, Kaufman HE, Investigation of pilocarpine-loaded polybutyl cyanoacrylate nanocapsules in collagen shields as a drug delivery system, Invest Opthalmol Vis Sci, 1990; 31, 485.
9. Lee VHL. Advances in drug delivery: recent development and future prospective. Pharmacy Int., 1985, 6, 135-137.
10. Yusif A. Industrial perspective in ocular drug delivery advance drug delivery 2005, 56 2, 514-581.
11. Ludwig A, Van Dotehgem M. Influence of the viscosity and the surface tension of opthalmic vehicles on the precorneal area of human eyes. Drug. Deli. Ind. Pharmacy, 1988; 14 2267-2284.
12. Davis JL, Gilger BC, Robinson MR. Novel approaches to ocular drug delivery. Curr Opin Mol Therap. 2004; 6:195-205.
13. Hsu J. Drug delivery methods for posterior segment disease. Curr Opin Ophthalmol 2007; 18, 235-239.
14. Klausner EA, Peer D, Chapman RL, Multack RF, Andurkar SV, Review Corneal gene therapy, Journal of Controlled Release 2007, 124, 107-133.
15. Selvam S, Thomas PB, Hamm-Alvarez SF, Schechter JE, Stevenson D, Mircheff AK, Trousdale MD, Current status of gene delivery and gene therapy in lacrimal gland using viral vectors, Advanced Drug Delivery Reviews, 2006; 58, 1243-1257.